Abbott Laboratories buy Piper Jaffray Companies
Start price
19.09.24
/
50%
€103.70
Target price
19.09.25
€117.65
Performance (%)
-2.78%
Price
26.09.24
€100.82
Summary
This prediction is currently active. With a performance of -2.78%, the BUY prediction for Abbott Laboratories by Piper_Jaffray_Compan is down slightly. This prediction currently runs until 19.09.25. The prediction end date can be changed by Piper_Jaffray_Compan at any time. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Abbott Laboratories | -2.127% |
| iShares Core DAX® | 0.936% |
| iShares Nasdaq 100 | 3.064% |
| iShares Nikkei 225® | 1.898% |
| iShares S&P 500 | 1.653% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat